Ann Palmenberg, professor of virology and biochemistry, explains how vaccines trick your immune system into thinking you’ve had an infection so you’ll be protected when a real virus comes along....
A startup led by a UW-Madison researcher is developing a method for testing the effect of certain chemicals on human brain and spinal cord development. Randolph Ashton is an associate professor of biomedical engineering at the university and the CEO and co-founder of Neurosetta LLC....
Nearly a mile beneath the Black Hills, in a gold mine in a South Dakota town called Lead, there is a hunt underway for theoretical particles known as WIMPs. But don’t let the acronym fool you. These WIMPs (which stands for weakly interacting massive particles)...
Whether they hate or love the high court’s ruling, those who believe in the urgency of climate change action should now place more trust in three forces – innovation, incentives and market adoption – that can move the dial. Wisconsin can be a poster child...
Two of the most common genetic changes that cause cells to become cancerous, which were previously thought to be separate and regulated by different cellular signals, are working in concert, according to new research from the University of Wisconsin–Madison. A team led by UW–Madison cancer...
Lab-grown human heart cells provide a powerful tool to understand and potentially treat heart disease. However, the methods to produce human heart cells from pluripotent stem cells are not optimal. Fortunately, a new study out of the University of Wisconsin–Madison Stem Cell & Regenerative Medicine...
Year in and year out, cement production is one of the biggest contributors to humanity’s carbon emissions. Making portland cement, the most frequently used cement around the world and a key component in concrete, releases about three billion metric tons of carbon dioxide per year....
DarkAero, the company launched by the Karl brothers in 2017 after they all quit their corporate jobs and pooled their savings, has grown into a full-service provider of aerospace composites training, classes and consulting, in addition to manufacturing and selling its signature product: an experimental...
FluGen announced the dosing of its first subject in an unprecedented study of older adults ages 65-85 years. The study will evaluate the safety, tolerability, and immunological response to FluGen's investigational supra-seasonal, live, single-replication, intranasal M2SR influenza (flu) vaccine....
Steve Carpenter, one of the world’s foremost lake ecologists and professor emerit at the University of Wisconsin–Madison, has been awarded the Blue Planet Prize. The Blue Planet Prize has been awarded annually by the Asahi Glass Foundation since 1992 to two individuals or organizations in...
During an eight-day visit to campus and the community last week, Jennifer Mnookin — who will begin her duties as UW–Madison’s next chancellor on Aug. 4 — met with students, staff and stakeholders and toured key campus facilities in preparation for her new role....
Ultima Genomics, Inc. and Exact Sciences Corporation (Nasdaq: EXAS) have entered a long-term supply agreement for Ultima's next-generation sequencing (NGS) technologies. ...